- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04718922
Chlorhexidine Mouthrinse Before EBUS-TBNA (CHX_EBUS)
Effect of Chlorhexidine Mouthrinse on Prevention of Microbial Contamination During EBUS-TBNA: a Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
EBUS-TBNA using the convex probe is a standard of care for the assessment of mediastinal and hilar lymphadenopathy. Although EBUS-TBNA is a minimally invasive procedure, rare but serious infectious complications such as pneumonia, lung abscess, empyema, mediastinal adenitis/abscess, mediastinitis, pericarditis, and sepsis were reported. EBUS-scope might be contaminated with oropharyngeal commensal bacteria while passing the oropharyngeal airway during EBUS-TBNA. Contamination of punctured lymph nodes by oropharyngeal commensal bacteria can cause severe infections.
Chlorhexidine gluconate is an antimicrobial agent that has a broad antibacterial activity including both gram-positive and negative bacteria. Chlorhexidine has been widely used for surgical scrub, skin disinfection, and mouthrinse. We, therefore, designed a phase 4, single-center, randomized, controlled clinical trial to investigate whether chlorhexidine mouthrinse is effective in preventing microbial contamination during EBUS-TBNA.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- inpatients aged 19 years and older who are scheduled to undergo EBUS-TBNA using a convex probe
Exclusion Criteria:
- antiseptic mouthrinse within 7 days before inclusion;
- active infection or antibiotic treatment within 7 days before inclusion;
- immunocompromised;
- trachemostomy status;
- who have already undergone gastroscopy on the same day when EBUS- TBNA is scheduled to be administered
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Arm
Mouthrinse with 100 ml 0.12% chlorhexidine for 1 min
|
Intervention with chlorhexidine mouthrinse will be performed approximately 10 min before the start of EBUS-TBNA
Other Names:
|
No Intervention: Control Arm
No mouthrinse
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Colony forming unit (CFU) counts of EBUS-TBNA needle wash solution in aerobic media
Time Frame: Needle wash solution is obtained immediately after termination of EBUS-TBNA
|
Needle wash solution is obtained by instilling 5mL of sterile physiological saline into the puncture needle.
|
Needle wash solution is obtained immediately after termination of EBUS-TBNA
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CFU counts of EBUS-TBNA needle wash solution in anaerobic media
Time Frame: Needle wash solution is obtained immediately after termination of EBUS-TBNA
|
Needle wash solution is obtained by instilling 5mL of sterile physiological saline into the puncture needle.
|
Needle wash solution is obtained immediately after termination of EBUS-TBNA
|
Fever
Time Frame: 24 hours after EBUS-TBNA
|
Fever is defined as a temperature ≥37.8°C.
|
24 hours after EBUS-TBNA
|
Infectious complications
Time Frame: 4 weeks after EBUS-TBNA
|
Infectious complications include pneumonia, lung abscess, empyema, mediastinal adenitis/abscess, mediastinitis, pericarditis, and sepsis.
|
4 weeks after EBUS-TBNA
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20110961173
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endobronchial Ultrasound
-
Postgraduate Institute of Medical Education and...Recruiting
-
Shanghai Chest HospitalUnknownEndobronchial Ultrasound
-
Bursa Uludag UniversitesiActive, not recruitingEndobronchial Ultrasound | CapnographyTurkey
-
Postgraduate Institute of Medical Education and...CompletedConscious Sedation During Procedure | Endobronchial UltrasoundIndia
-
Seoul National University HospitalCompletedEndobronchial Ultrasound Guided Transbronchial Needle AspirationKorea, Republic of
-
Duke UniversityTerminatedENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION | Benign and Malignant Mediastinal and Hilar Lymph Nodes Known or Suspected MalignancyUnited States
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HF; SINTEF Health ResearchRecruitingLung Cancer | Artificial Intelligence | Endobronchial UltrasoundNorway
-
Imam Abdulrahman Bin Faisal UniversityRecruitingEndobronchial IntubationSaudi Arabia
-
Medical University of ViennaCompletedEndobronchial Intubation
-
St. Joseph's Healthcare HamiltonCompletedNSCLC | Lung Cancer | Artificial Intelligence | Elastography | Endobronchial UltrasoundCanada
Clinical Trials on Chlorhexidine Gluconate 0.12 % Mouthwash
-
University of OsloGöteborg UniversityCompletedDental Caries | Periodontal Disease
-
University of OsloUnknown
-
University of TaubateConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownPeriodontitis | Normal Blood PressureBrazil
-
University of MilanCompleted
-
University of BaghdadCompletedPeriodontal Diseases | Mouth Diseases | Plaque Induced Gingivitis | Bleeding GumIraq
-
Aravena, Pedro, DDS, PhDUniversidad Austral de ChileCompleted
-
King Abdulaziz UniversityCompletedGingivitis | Dental PlaqueSaudi Arabia
-
Al-Iraqia UniversityCompleted
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI); University of Pittsburgh; National...WithdrawnPulmonary Hypertension | Heart Failure With Normal Ejection Fraction | Pulmonary Heart Disease and Diseases of Pulmonary CirculationUnited States
-
Universidad de GuanajuatoUnknownVentilator Associated Pneumonia | ChlorhexidineMexico